Add BrightSurf on Google Email

Come here and be quiet!

A novel technique identified an unusually strong 3D network of developmental genes in ESCs, physically clustered and silenced by Polycomb repressive complex (PRC1) to maintain the undifferentiated state. This mechanism allows for selective release of genes, controlling early development decisions.

SourceBabraham Institute·JournalNature Genetics·DateAug 31, 2015

Major breakthrough in understanding Prader-Willi Syndrome, a parental imprinting disorder

Scientists at the Hebrew University of Jerusalem have reported a major breakthrough in understanding the molecular basis for Prader-Willi syndrome (PWS), a disease that involves defects in parental imprinting. The researchers created a model for PWS by reprogramming skin cells from patients into embryonic-like cells, showing that pater...

SourceThe Hebrew University of Jerusalem·JournalNature Genetics·DateMay 12, 2014

Aging erodes genetic control, but that's flexible

Biologists at Brown University found that gene silencing via chromatin in fruit flies declines with age, but administering life span extending measures such as lower calorie diets or increased expression of the protein Sir2 restores the loss of gene silencing due to age. The study suggests a possible line of research to develop more pr...

Cancer epigenetics: Breakthrough in ID'ing target genes

A new study from Rice University and Baylor College of Medicine has developed a computer program called EpiPredictor to rapidly identify genes targeted by epigenetic proteins. The program, which was funded in part by the Cancer Prevention Research Institute of Texas, shows promise for speeding up research in cancer epigenetics.

SourceRice University·JournalNucleic Acids Research·DateMar 13, 2012

A question of gene silencing

Researchers have created a method for silencing non-protein-coding genes using zinc finger nucleases. This allows for the study of these genes' molecular and cellular functions, which are thought to play a role in cancer development.

SourceHelmholtz Association·JournalGenome Research·DateAug 24, 2011

Olivier Voinnet awarded 2009 EMBO Gold Medal

Olivier Voinnet's groundbreaking research on gene silencing via RNA has opened new perspectives on controlling gene activity, with implications for medicine and genome integrity. His work has also shed light on the molecular arms race between hosts and parasites.

SourceEMBO·DateApr 22, 2009

New gene-silencing pathway found in plants

A team led by Craig Pikaard discovered a new mechanism by which plant cells silence potentially harmful genes, involving the non-coding region of DNA and two plant-specific RNA polymerases. The research has major implications for gene therapy, where RNA-centric approaches show promise for controlling diseases such as cancer and HIV.

Turn-ons and turn-offs for neurons

Researchers found that genes in the adult brain can be silenced or unsilenced by regulating gene accessibility without changing DNA sequences. This discovery has significant implications for studying gene function and neuronal physiology.

SourcePLOS·JournalPLOS ONE·DateJun 19, 2007

New genetic hypothesis for the cause of autism

A new genetic hypothesis proposes that most cases of autism can be explained by a complex model for genetic malfunction, involving both inherited and de novo genetic factors. The study suggests epigenetic components, including genetic imprinting, play a major role in the etiology of autism.

SourceWiley·JournalAmerican Journal of Medical Genetics·DateSep 8, 2004

The silence of the genes

Researchers from USC provide a new perspective on treating genetic disorders by switching genes back on using epigenetic therapy. Several chemical compounds have been found to affect epigenetic gene changes and are being tested in clinical trials, including one recently approved for myelodysplastic syndrome.

Breaking the silence: Discovery could lead to new treatments for cancer, sickle-cell anemia

Scientists at Fred Hutchinson Cancer Center have discovered a potential new treatment for cancer and sickle-cell anemia by inhibiting gene silencing. The compound, splitomicin, effectively blocks the silencing of genes critical for healthy growth and may also be effective against certain cancers.

SourceFred Hutchinson Cancer Center·JournalProceedings of the National Academy of Sciences·DateDec 17, 2001